ENTEROSORBENT AND METHOD OF PREPARATION THEREOF

medicinal polymers. SUBSTANCE: invention relates to enterosorbent based on microcrystalline cellulose that can be used for treating acute and chronic infections, exogenous and endogenous intoxications, disturbances of the fat and other types of metabolism and to microcrystalline cellulose technology...

Full description

Saved in:
Bibliographic Details
Main Authors KHARITONOV V.F, LEVANOVA V.P, KOROL'KOVA S.V, ARTEM'EVA I.S, POLLE S.N, SOLOMENNIKOV A.V, VORONOV A.F, BELJAKOV N.A, MAR'INA V.F, ISAEVA L.V
Format Patent
LanguageEnglish
Russian
Published 20.06.2000
Edition7
Subjects
CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY
CHEMISTRY
COMPOSITIONS BASED THEREON
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC MACROMOLECULAR COMPOUNDS
PERFORMING OPERATIONS
PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
POLYSACCHARIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
THEIR PREPARATION OR CHEMICAL WORKING-UP
THEIR RELEVANT APPARATUS
TRANSPORTING
Online AccessGet full text

Cover

More Information
Summary:medicinal polymers. SUBSTANCE: invention relates to enterosorbent based on microcrystalline cellulose that can be used for treating acute and chronic infections, exogenous and endogenous intoxications, disturbances of the fat and other types of metabolism and to microcrystalline cellulose technology. Powdered enterosorbent, in particular, contains 50-60% of microcrystalline cellulose particle fraction 4-100 mcm and 40-50% of fraction 100-400 mcm. Enterosorbent is prepared by hydrolysis of native or extracted from vegetable tissues cellulose with 0.5-1.5% aqueous mineral acid solution at 110-130 C for 5 to 15 min followed by drying, disintegration, and fractionation to pick of microcrystalline cellulose particle fraction 40-400 mcm. EFFECT: increased sorption capacity. 4 cl, 2 tbl, 2 ex
Bibliography:Application Number: RU19990102628